Aspirin Use is Associated with Reduced Risk of Cholangiocarcinoma

被引：0
|
作者：
Choi, Jonggi [1 ,2 ]
Ghoz, Hassan M. [1 ,2 ]
Peeraphatdit, Thoetchai [1 ,2 ,3 ]
Baichoo, Esha [1 ,2 ,4 ]
Addissie, Benyam D. [1 ,2 ]
Harmsen, William S. [5 ]
Therneau, Terry M. [5 ]
Olson, Janet E. [5 ,6 ]
Chaiteerakij, Roongruedee [1 ,2 ,7 ,8 ]
Roberts, Lewis R. [1 ,2 ]
机构：
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA
[2] Mayo Clin, Ctr Canc, Rochester, MN USA
[3] Univ Minnesota, Dept Internal Med, Minneapolis, MN USA
[4] Mt Sinai Roosevelt Hosp, Dept Med, New York, NY USA
[5] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA
[6] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA
[7] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand
[8] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
397
引用
收藏
页码：410A / 411A
页数：2
相关论文
共 50 条
  • [1] ASPIRIN USE IS ASSOCIATED WITH A LOWER RISK OF CHOLANGIOCARCINOMA
    Mbakop, Raissa Nana Sede
    Forlemu, Arnold N.
    Amakye, Dominic
    Bandaru, Praneeth K.
    Gayam, Vijay
    Kumar, Vikash
    Ronda, Vishnu Poojitha
    Garlapati, Pavani
    Reddy, Madhavi
    GASTROENTEROLOGY, 2023, 164 (06) : S611 - S612
  • [2] Aspirin use is associated with a reduced risk of cholangiocarcinoma: a systematic review and meta-analysis
    Xiong, Jianping
    Xu, Weiyu
    Bian, Jin
    Huang, Hanchun
    Bai, Yi
    Xu, Yiyao
    Lu, Xin
    Zhao, Haitao
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 4095 - 4104
  • [3] Aspirin use and the risk of cholangiocarcinoma
    Choi, Jonggi
    Ghoz, Hassan M.
    Peeraphatdit, Thoetchai
    Baichoo, Esha
    Addissie, Benyam D.
    Harmsen, William S.
    Therneau, Terry M.
    Olson, Janet E.
    Chaiteerakij, Roongruedee
    Roberts, Lewis R.
    HEPATOLOGY, 2016, 64 (03) : 785 - 796
  • [4] Aspirin use and the risk of cholangiocarcinoma
    Lai, Shih-Wei
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2019, 112 (08) : 643 - 643
  • [5] ASPIRIN USE ASSOCIATED WITH REDUCED RISK OF CANCER
    不详
    AMERICAN JOURNAL OF NURSING, 2017, 117 (06) : 70 - 70
  • [6] Aspirin use is associated with reduced risk for hepatocellular carcinoma
    Koretz, Ronald L.
    ANNALS OF INTERNAL MEDICINE, 2022,
  • [7] Aspirin use is associated with reduced risk for hepatocellular carcinoma
    Koretz, Ronald L.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (07)
  • [8] Aspirin Use Is Associated With Reduced Risk of Occlusion of Metallic Biliary Stents
    Jang, Sunguk
    Stevens, Tyler
    Parsi, Mansour A.
    Lopez, Rocio
    Vargo, John J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (03) : 446 - 453
  • [9] ASPIRIN USE IS ASSOCIATED WITH REDUCED RISK OF GASTRIC ADENOCARCINOMA AMONG WOMEN BUT NOT MEN
    Kwon, Sohee
    Ma, Wenjie
    Cao, Yin
    Giovannucci, Edward
    Bao, Ying
    Fuchs, Charles S.
    Chan, Andrew T.
    GASTROENTEROLOGY, 2020, 158 (06) : S71 - S71
  • [10] Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study
    Shebl, F. M.
    Sakoda, L. C.
    Black, A.
    Koshiol, J.
    Andriole, G. L.
    Grubb, R.
    Church, T. R.
    Chia, D.
    Zhou, C.
    Chu, L. W.
    Huang, W-Y
    Peters, U.
    Kirsh, V. A.
    Chatterjee, N.
    Leitzmann, M. F.
    Hayes, R. B.
    Hsing, A. W.
    BRITISH JOURNAL OF CANCER, 2012, 107 (01) : 207 - 214
12345